
M3 Biotechnology raises $10M for drugs that “can regrow brain cells”
The regenerative medicine company says it has a small molecule in the works that could help regrow brain cells in Alzheimer's and Parkinson's disease.
The regenerative medicine company says it has a small molecule in the works that could help regrow brain cells in Alzheimer's and Parkinson's disease.
A patient will undergo deep brain stimulation surgery, in which they are awake and communicating, live on television for the first time.
It has been mysterious as to why only certain parts of the brain are affected with Parkinson's disease. Now researchers believe they have figured out what makes those brain cells unique.
New, wearable technology not only helps monitor symptoms automatically, it may be able to predict seizures and disease progression in patients with neurological disorders.
The way we sleep plays in a role in how our brains get rid of what is considered neurological waste.
Neuro Vigor, a startup based in Indiana, has a new theory for what causes multiple sclerosis — and has found a generic hypertension drug that could potentially be repurposed to treat an array of neurodegenerative diseases.
The mPower app helps Parkinson's disease patients track metrics such as dexterity, balance, gait, voice patterns and cognition, then send readings to researchers.
For diseases like Parkinson’s and Alzheimer’s, it seems like symptoms are a function of what’s going on deep down inside of whoever is afflicted – a reflection of something happening at the core. But what if detection could be right in front of our faces, just on the surface of a patient’s skin? Dr. Ildefonso […]
Providers have been looking for devices that can effectively track chronic diseases or neurological disorders,and they may have found one in the way of sensors that do so with the progression of Parkinson’s disease, according to research by UT Southwestern Medical Center. A portable set sensors, known as the APDM Mobility Lab, have shown success […]
Palo Alto biotech Gardedam Therapeutics is taking the crowdfunding route to raise $195,000 funding for its Parkinson’s and Alzheimer’s disease drug candidate. And it’s offering up perks like personal lab tours in Cambridge or Budapest, or the opportunity to rename a lead drug candidate to the donors that pony up more than $50,000. Donors at the […]
Break down the silos. Take control of your provider data.
MedCity News has partnered with BioCrossroads to provide coverage focused on Indiana’s next generation of growth and innovation in life sciences. Only 5.8% of the student population is enrolled in the Pharmacy, Nursing and Health Sciences programs at Purdue University, but healthcare startups make up half of the university’s new Startup Class of 2014. Twelve […]
The Food and Drug Administration has been very active on the mobile health front this year and has cleared 23 mhealth apps as medical devices for the year to date from data aggregators and thermometers to remote monitoring devices to detect motion, posture and vitals, according to Mobihealthnews. Cardiology has dominated , accounting for seven […]
The latest addition to Google’s lineup of consumer health products is a small San Francisco design firm with a creative solution to make daily life a little easier for seniors with essential tremor or Parkinson’s disease. Lift Labs designed a spoon with some fancy electronics in the handle. The handle senses the movement of a […]
There’s a generalized consensus that “good” fats – like Omega-3 fatty acids – could help improve mental acuity, even combat neurodegenerative disease. Bay Area startup Retrotope is riffing off this idea, engineering what could be a super-good fat that treats aging-related conditions like Alzheimer’s, Parkinson’s and diabetic retinopathy. It just received $6.5 million in angel funding to bring its fatty drug to the […]
Scientists suspect there’s a connection between many common neurodegenerative diseases and malfunctioning lysosomes, or processing centers in human cells that break down proteins and eliminate debris. Now a new company called Lysosomal Therapeutics is tapping into the relationship between the two to discover and develop new treatments for rare diseases and common neurodegenerative diseases, starting […]